Your browser doesn't support javascript.
loading
DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines.
Zhao, Ya-Hui; Jiang, Wei; Gao, Hai; Pang, Guo-Zheng; Wu, Yu-Shuang; Wang, Yuan-Xian; Sheng, Meng-Yao; Xie, Jia-Ying; Wu, Wan-Ling; Ji, Zhi-Jian; Du, Ya-Rui; Zhang, Lei; Wang, Xiao-Qin; Walsh, Colum P; Jiang, Hai; Xu, Guo-Liang; Zhou, Dan.
Affiliation
  • Zhao YH; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Jiang W; State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • Gao H; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Pang GZ; Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University, Shanghai 201399, China.
  • Wu YS; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Wang YX; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Sheng MY; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Xie JY; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Wu WL; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai 200032, China.
  • Ji ZJ; Department of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, China.
  • Du YR; State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • Zhang L; State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • Wang XQ; Department of Chemistry and Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Walsh CP; Department of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, China.
  • Jiang H; Genomic Medicine Research Group, Biomedical Sciences, Ulster University, Coleraine BT52 1SA, United Kingdom.
  • Xu GL; Centre for Research and Development, Region Gävleborg/Uppsala University, Gävle SE-801 87, Sweden.
  • Zhou D; State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
Protein Cell ; 14(7): 532-537, 2023 06 28.
Article in En | MEDLINE | ID: mdl-37378658
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gemcitabine / Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Protein Cell Journal subject: BIOQUIMICA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gemcitabine / Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Protein Cell Journal subject: BIOQUIMICA Year: 2023 Document type: Article Affiliation country: Country of publication: